Schedule of Aprameya Engineering
| Issue open date | 25 Jul 2024 |
| Issue close date | 29 Jul 2024 |
| UPI mandate deadline | 29 Jul 2024 (5 PM) |
| Allotment finalization | 30 Jul 2024 |
| Refund initiation | 31 Jul 2024 |
| Share credit | 31 Jul 2024 |
| Listing date | 01 Aug 2024 |
| Mandate end date | 13 Aug 2024 |
| Lock-in end date for anchor investors (50%) | 29 Aug 2024 |
| Lock-in end date for anchor investors (remaining) | 29 Oct 2024 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Aprameya Engineering
Founded in 2003, Aprameya Engineering Limited is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres, and prefabricated structure ward in the hospitals and medical care centres on a turnkey basis along with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners. The company’s portfolio of products and services can be classified into two different segments:
- Setting up of healthcare infrastructure within the hospitals
- Dealing in high-value medical equipment
The company started the business of setting up ICUs and operation theatres in 2020 and has since then completed the installation of around 2000 critical care beds including ICUs, NICUs, PICUs, and modular operation theatres across the state of Rajasthan. During the Fiscal year 2024, The company has undertaken setting up, installing, and commissioning dialysis centres for Rajasthan Services Medical Corporation Limited in over 150 different locations in the state of Rajasthan.
Financials of Aprameya Engineering
Issue size
| Funds raised in the IPO | Amount |
| Overall | ₹29.23 crores |
| Fresh issue | ₹29.23 crores |
| Offer for sale | – |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Working Capital requirements | 21 (71.85%) |
| General corporate purpose | 8.23 (28.15%) |
*All figures except EPS are in ₹ crores
Strengths
- Asset-light scalable business model: The company’s business model being service-oriented, is an asset-light business and does not require large investment in fixed assets to increase business operations. They also have a track record of delivering consistent growth along with high capital efficiency with low debt funding.
- Wide customer base including many Private and Government Hospitals/Medical colleges: The company’s wide customer base includes various private hospitals, government hospitals, medical practitioners, medical colleges including AIIMS, and diagnostic centres across the country.
- Rapid growth in the business with a focus on setting up healthcare infrastructure: The company has over 20 years of experience in the field of providing solutions through dealing in medical and healthcare equipment and has entered into distributor and service agreements with medical device suppliers. Since 2020, They have executed the installation of around 2000 critical care beds including Intensive Care Units (ICU), Neonatal Intensive Care Units (NICUs), Pediatric Intensive Care Units (PICU), and operation theatre.
Risks
- Highly competitive Industry: The company operates in a highly competitive industry and its success depends on its ability to anticipate, understand, and address the preferences of its existing and prospective customers as well as to understand evolving industry trends. Any failure to adequately do so could adversely affect its business.
- Geographical concentration: The company generates nearly 58% of its revenues from the state of Rajasthan. Any adverse development affecting the operations in this region could have an adverse impact on the business, financial condition, and results of operations.
- Reliance on top clients: The company derives nearly 79% portion of its revenue from its top ten customers. Any reduction in business from these top five customers or any other major clients could have negative implications for both revenue and profitability.
Note:
- The above schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion.
- The allotment status will be available by July 31, 2024, on the registrar’s website and the NSE website.